Wikidata

(Q40578614)

English

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma

scientific article published on July 2003

In more languages

Statements

title
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
main subject
thalidomide
0 references
temozolomide
0 references
author name string
S Danson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
A Clamp
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
M Ranson
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
J Hodgetts
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
L Lomax
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
L Ashcroft
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
N Thatcher
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
M R Middleton
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
publication date
1 July 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017
page(s)
2551-2557
1 reference
stated in
Europe PubMed Central
PubMed ID
12829675
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40578614&oldid=1903223388"